S. Livolti et al., HYPORESPONSIVENESS TO INTRADERMAL ADMINISTRATION OF HEPATITIS-B VACCINE IN INSULIN-DEPENDENT DIABETES-MELLITUS, Archives of Disease in Childhood, 78(1), 1998, pp. 54-57
The immune response to intradermal or intramuscular hepatitis B vaccin
e in 18 children with insulin dependent diabetes (IDDM) compared with
24 healthy children was studied. Patients were divided into responders
, hyporesponders, and non-responders according to their antihepatitis
B serum concentrations after hepatitis B vaccination. We also studied
HLA class II antigen distribution and did delayed type hypersensitivit
y (DTH) tests on children with IDDM and controls. No difference in the
immune response (antihepatitis B surface antigen antibody titres) was
found with intramuscular administration, whereas with intradermal adm
inistration a statistically lower immune response (p < 0.001) was obse
rved in children with IDDM v controls. This hyporesponsiveness cannot
be attributed to HLA class II antigen distribution because their frequ
ency was the same in both groups of children with IDDM. It is suggeste
d that the poor immune response to intradermal hepatitis B vaccine may
be due to impaired macrophage activity resulting in failure of antige
n presentation, which may be of importance in the immune dysfunction i
n children with IDDM. This hypothesis is suggested by a significantly
lower score on a DTH test to a battery of antigens in the IDDM group w
hen compared with controls. It is therefore suggested that when the he
patitis B vaccination is offered to children with IDDM it may be prefe
rable to give it intramuscularly.